Collaborative Research & Investigator Sponsored Studies Programs
Collaborative Research & Investigator Sponsored Studies Programs support researchers studying Teva products, diseases, treatments, and medicine use to deepen scientific and medical understanding.
Funder: Teva
Due Dates: No deadline stated
Funding Amounts: ISS support may include funding and/or product supply
Summary: Teva considers investigator-sponsored studies and collaborative research that advance understanding of its products, diseases, and treatments.
Key Information: ISS proposals must be investigator-initiated and unsolicited by Teva.
Description
Teva’s Collaborative Research and Investigator Sponsored Studies (ISS) programs support research that furthers understanding of its products, disease entities, treatment paradigms, and the appropriate use of medicines. Clinical researchers can propose studies of a particular treatment in a specific patient population. An ISS is an independent investigation initiated and conducted by a non-industry investigator who assumes the study sponsor’s responsibilities.
ISS proposals may involve clinical, pre-clinical, or non-clinical work, including interventional, observational, epidemiological, and health economic or outcomes research. Teva publishes non-exclusive areas of interest in neurology and psychiatry; proposals outside those areas may also be considered if they align with its scientific and medical interests.
